Literature DB >> 11238879

Repair of a Rev-minus human immunodeficiency virus type 1 mutant by activation of a cryptic splice site.

K Verhoef1, P S Bilodeau, J L van Wamel, J Kjems, C M Stoltzfus, B Berkhout.   

Abstract

We isolated a revertant virus after prolonged culturing of a replication-impaired human immunodeficiency virus type 1 (HIV-1) mutant of which the Rev open reading frame was inactivated by mutation of the AUG translation initiation codon. Sequencing of the tat-rev region of this revertant virus identified a second-site mutation in tat that restored virus replication in the mutant background. This mutation activated a cryptic 5' splice site (ss) that, when used in conjunction with the regular HIV 3' ss #5, fuses the tat and rev reading frames to encode a novel T-Rev fusion protein that rescues Rev function. We also demonstrate an alternative route to indirectly activate this cryptic 5' ss by mutational inactivation of an adjacent exon splicing silencer element.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11238879      PMCID: PMC114146          DOI: 10.1128/JVI.75.7.3495-3500.2001

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  25 in total

1.  Multiple splicing defects in an intronic false exon.

Authors:  H Sun; L A Chasin
Journal:  Mol Cell Biol       Date:  2000-09       Impact factor: 4.272

2.  A novel human immunodeficiency virus type 1 protein, tev, shares sequences with tat, env, and rev proteins.

Authors:  D M Benko; S Schwartz; G N Pavlakis; B K Felber
Journal:  J Virol       Date:  1990-06       Impact factor: 5.103

3.  Comparison of Rous sarcoma virus RNA processing in chicken and mouse fibroblasts: evidence for double-spliced RNA in nonpermissive mouse cells.

Authors:  S L Berberich; M Macias; L Zhang; L P Turek; C M Stoltzfus
Journal:  J Virol       Date:  1990-09       Impact factor: 5.103

4.  Control of retroviral RNA splicing through maintenance of suboptimal processing signals.

Authors:  R A Katz; A M Skalka
Journal:  Mol Cell Biol       Date:  1990-02       Impact factor: 4.272

5.  Multiple regions in the Rous sarcoma virus src gene intron act in cis to affect the accumulation of unspliced RNA.

Authors:  C M Stoltzfus; S J Fogarty
Journal:  J Virol       Date:  1989-04       Impact factor: 5.103

6.  Splicing regulatory elements within tat exon 2 of human immunodeficiency virus type 1 (HIV-1) are characteristic of group M but not group O HIV-1 strains.

Authors:  P S Bilodeau; J K Domsic; C M Stoltzfus
Journal:  J Virol       Date:  1999-12       Impact factor: 5.103

7.  A novel subgenomic murine leukemia virus RNA transcript results from alternative splicing.

Authors:  J Déjardin; G Bompard-Maréchal; M Audit; T J Hope; M Sitbon; M Mougel
Journal:  J Virol       Date:  2000-04       Impact factor: 5.103

8.  A second-site mutation that restores replication of a Tat-defective human immunodeficiency virus.

Authors:  K Verhoef; B Berkhout
Journal:  J Virol       Date:  1999-04       Impact factor: 5.103

9.  Regulation of Rous sarcoma virus RNA splicing and stability.

Authors:  S Arrigo; K Beemon
Journal:  Mol Cell Biol       Date:  1988-11       Impact factor: 4.272

10.  A tripartite HIV-1 tat-env-rev fusion protein.

Authors:  J Salfeld; H G Göttlinger; R A Sia; R E Park; J G Sodroski; W A Haseltine
Journal:  EMBO J       Date:  1990-03       Impact factor: 11.598

View more
  2 in total

Review 1.  Unusual Fusion Proteins of HIV-1.

Authors:  Simon Langer; Daniel Sauter
Journal:  Front Microbiol       Date:  2017-01-09       Impact factor: 5.640

2.  Dynamic regulation of HIV-1 mRNA populations analyzed by single-molecule enrichment and long-read sequencing.

Authors:  Karen E Ocwieja; Scott Sherrill-Mix; Rithun Mukherjee; Rebecca Custers-Allen; Patricia David; Michael Brown; Susana Wang; Darren R Link; Jeff Olson; Kevin Travers; Eric Schadt; Frederic D Bushman
Journal:  Nucleic Acids Res       Date:  2012-08-25       Impact factor: 16.971

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.